Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
This is an open label pilot study of 40 evaluable patients receiving vinorelbine-gemcitabine
combination chemotherapy with filgrastim support in an outpatient setting. Participating
patients at the time of registration will have measurable relapsed or primary refractory
lymphoma.